Zotero Mendeley EndNote BibTex Kaynak Göster

-

Yıl 2003, Cilt 34, Sayı 4, 19 - 21, 01.05.2003

Öz

-

Kaynakça

  • 1. Zaloudek CJ, Hendrickson MR. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein's Pathology of Female Genital Tract. 5th ed. New York: Springer-Verlag 2 002: 561-616
  • 2. Buttrom VC, Reiter RC. Uterine leiomyomata: etiology symptomatology and management. Fertil Steril 1981, 36:433-5
  • 3. Kamaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T. Mitotik activity in uterine leimyoma during the menstrual cycle. Am J Obstet Gynecoll989; 160: 637-41
  • 4. Kawaguchi K, Fujii S, Konishi I, et al
  • Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstruial cycle and pregnancy. Virchoows Arch PatholAnat 1991, 419: 309-15
  • 5. Brandon DD, Bethea CL, Strawn EY, et al
  • Progesterone receptor messenger ribonucleic acid and protein are overexpresses in human uterine leiomyomas. Am ] Obstet Gynecol 1993; 169: 78- 85
  • 6. Mittal K, Popiolek D, Demopoulos Rl. Uterine myxoid leiomyosarcoma within a leiomyoma. Human Pathol 2000; 31: 398-400
  • 7. Scurry}, FRCPA, Hack M. Leiomyosarcoma arising in a lipoleiomyosarcoma. Gynecol Oncol 1990; 39: 381-3
  • 8. Montague A, Swariz DP, Woodruff JD. Sarcoma arising in leiomyoma of uterus. Am J Obstet Gynecol 1965; 92: 421-7
  • 9. Hendrickson MR, Kempson RL. Pure mesenchymal neoplasms of the uterine corpus. In; FoxH, Wells M. Eds. Obstetrical and Gynecological Pathology. Vol 1. 5th edn. Edinburg, London ; Churchill Livingstone; 2003 : 497-548
  • 10. Carcangiu ML, Chambers JT, VaynickIM, Pino M, Schwartz PE. Immunhis to chemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol 1990; 94: 247-54
  • 11. Kounelis S, Kapranos N, Kouri E. Et al
  • Immuno his to chemical profile of endometrial adenocarcinoma: astudy of 61 cases and review of the literature. Mod Pathol 2000; 13: 379-88
  • 12. Pertschuk LP, Masood S, Simone J. et al Estrogen receptor immuno cytochemistry in endometrial carcinoma: a prognostic marker for survival. Gynecol Oncol 1996; 63: 28-33
  • 13. Fukuda K, MoriM, Uchiyama M, IwaiK, Iwasaka T, Sugimori H. Prognostic significance of progesterone receptor immuno his to chemistry in endometrial carcinoma. Gynecol Oncol 1998; 69: 220-5
  • 14. Sivridis E, GiatromanolakiA, Koukourakis M, Anastasiadis P. Endometrial carcinoma: association with low angiogenesis andbcl-2 expression. Vfrhows Arch 2001; 438: 470-7
  • 15. IwaiK, Fukuda K, Hachisuga T. Etal. Prognostic signicance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma. Gynecol Oncol 1999; 72: 351-9
  • 16. ZhaiYL, KobayashiY, Mori A et al. Expression of steroid receptors, Ki-67 and p 53 in uterine leiomyosarcomas. IntJ Gynecol Pathol 1999; 18: 20-8
  • 17. Mittal K, Demopoulos RI. MIB-1 (Ki-67), p 53, estrogen receptor and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 2001; 32: 984-7

Estrogen and progesteron receptor expression in cellular leiomyomas and leiomyosarcomas

Yıl 2003, Cilt 34, Sayı 4, 19 - 21, 01.05.2003

Öz

Objective:To evaluate estrogen(ER) and progesteron(PR) receptor expression in cellular leiomyomas and leiomyosarcomas Materials and Methods: The study includes 17 cases of cellular leiomyoma(CM) and 7 cases of leiomyosarcoma(LMS) which were diagnosed in Pathology Department of Zeynep Kamil Hoşpital between 1997 and 2003 years. One paraffin-embedded tümör tissue per each case were analyzed immunohistochemically for ER and PR ,receptors. Results: None of LMSs showed 'overexpression' for PR. Out-of 17 CMs 13 showed PR overexpression.(LMS PR overexpressionxCMPR overexpression,p

Kaynakça

  • 1. Zaloudek CJ, Hendrickson MR. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein's Pathology of Female Genital Tract. 5th ed. New York: Springer-Verlag 2 002: 561-616
  • 2. Buttrom VC, Reiter RC. Uterine leiomyomata: etiology symptomatology and management. Fertil Steril 1981, 36:433-5
  • 3. Kamaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T. Mitotik activity in uterine leimyoma during the menstrual cycle. Am J Obstet Gynecoll989; 160: 637-41
  • 4. Kawaguchi K, Fujii S, Konishi I, et al
  • Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstruial cycle and pregnancy. Virchoows Arch PatholAnat 1991, 419: 309-15
  • 5. Brandon DD, Bethea CL, Strawn EY, et al
  • Progesterone receptor messenger ribonucleic acid and protein are overexpresses in human uterine leiomyomas. Am ] Obstet Gynecol 1993; 169: 78- 85
  • 6. Mittal K, Popiolek D, Demopoulos Rl. Uterine myxoid leiomyosarcoma within a leiomyoma. Human Pathol 2000; 31: 398-400
  • 7. Scurry}, FRCPA, Hack M. Leiomyosarcoma arising in a lipoleiomyosarcoma. Gynecol Oncol 1990; 39: 381-3
  • 8. Montague A, Swariz DP, Woodruff JD. Sarcoma arising in leiomyoma of uterus. Am J Obstet Gynecol 1965; 92: 421-7
  • 9. Hendrickson MR, Kempson RL. Pure mesenchymal neoplasms of the uterine corpus. In; FoxH, Wells M. Eds. Obstetrical and Gynecological Pathology. Vol 1. 5th edn. Edinburg, London ; Churchill Livingstone; 2003 : 497-548
  • 10. Carcangiu ML, Chambers JT, VaynickIM, Pino M, Schwartz PE. Immunhis to chemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol 1990; 94: 247-54
  • 11. Kounelis S, Kapranos N, Kouri E. Et al
  • Immuno his to chemical profile of endometrial adenocarcinoma: astudy of 61 cases and review of the literature. Mod Pathol 2000; 13: 379-88
  • 12. Pertschuk LP, Masood S, Simone J. et al Estrogen receptor immuno cytochemistry in endometrial carcinoma: a prognostic marker for survival. Gynecol Oncol 1996; 63: 28-33
  • 13. Fukuda K, MoriM, Uchiyama M, IwaiK, Iwasaka T, Sugimori H. Prognostic significance of progesterone receptor immuno his to chemistry in endometrial carcinoma. Gynecol Oncol 1998; 69: 220-5
  • 14. Sivridis E, GiatromanolakiA, Koukourakis M, Anastasiadis P. Endometrial carcinoma: association with low angiogenesis andbcl-2 expression. Vfrhows Arch 2001; 438: 470-7
  • 15. IwaiK, Fukuda K, Hachisuga T. Etal. Prognostic signicance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma. Gynecol Oncol 1999; 72: 351-9
  • 16. ZhaiYL, KobayashiY, Mori A et al. Expression of steroid receptors, Ki-67 and p 53 in uterine leiomyosarcomas. IntJ Gynecol Pathol 1999; 18: 20-8
  • 17. Mittal K, Demopoulos RI. MIB-1 (Ki-67), p 53, estrogen receptor and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 2001; 32: 984-7

Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu

Yıl 2003, Cilt 34, Sayı 4, 19 - 21, 01.05.2003

Öz

Amaç: Selüler leiomyom ve leimyo sarkomların Ostrojen ve progesteron reseptör ekspresyonlarını değerlendirmek. Materyal ve Method: 1997-2003 yıUarı arasında Zeynep Kamil Hastanesi Patoloji Bölümünde tanı almış 17 selüler leimyom ve 7 leiomyosarkom olgusu çalışma kapsamına alındı. Tümörleri temsil eden birer parafin blokda immunhisto kimyasal yöntemle östrojen ve progesteron reseptör boyanması incelendi. Bulgular: Leiomy'Osarkomların hiçbirinde progesteron resptörü için "overexpression"'(OE) izlenmedi. Onyedi adet selüler leibmyomun 13 ünde OE saptandı (LMS PR-OE x SM PR-OE, p

Kaynakça

  • 1. Zaloudek CJ, Hendrickson MR. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein's Pathology of Female Genital Tract. 5th ed. New York: Springer-Verlag 2 002: 561-616
  • 2. Buttrom VC, Reiter RC. Uterine leiomyomata: etiology symptomatology and management. Fertil Steril 1981, 36:433-5
  • 3. Kamaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T. Mitotik activity in uterine leimyoma during the menstrual cycle. Am J Obstet Gynecoll989; 160: 637-41
  • 4. Kawaguchi K, Fujii S, Konishi I, et al
  • Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstruial cycle and pregnancy. Virchoows Arch PatholAnat 1991, 419: 309-15
  • 5. Brandon DD, Bethea CL, Strawn EY, et al
  • Progesterone receptor messenger ribonucleic acid and protein are overexpresses in human uterine leiomyomas. Am ] Obstet Gynecol 1993; 169: 78- 85
  • 6. Mittal K, Popiolek D, Demopoulos Rl. Uterine myxoid leiomyosarcoma within a leiomyoma. Human Pathol 2000; 31: 398-400
  • 7. Scurry}, FRCPA, Hack M. Leiomyosarcoma arising in a lipoleiomyosarcoma. Gynecol Oncol 1990; 39: 381-3
  • 8. Montague A, Swariz DP, Woodruff JD. Sarcoma arising in leiomyoma of uterus. Am J Obstet Gynecol 1965; 92: 421-7
  • 9. Hendrickson MR, Kempson RL. Pure mesenchymal neoplasms of the uterine corpus. In; FoxH, Wells M. Eds. Obstetrical and Gynecological Pathology. Vol 1. 5th edn. Edinburg, London ; Churchill Livingstone; 2003 : 497-548
  • 10. Carcangiu ML, Chambers JT, VaynickIM, Pino M, Schwartz PE. Immunhis to chemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol 1990; 94: 247-54
  • 11. Kounelis S, Kapranos N, Kouri E. Et al
  • Immuno his to chemical profile of endometrial adenocarcinoma: astudy of 61 cases and review of the literature. Mod Pathol 2000; 13: 379-88
  • 12. Pertschuk LP, Masood S, Simone J. et al Estrogen receptor immuno cytochemistry in endometrial carcinoma: a prognostic marker for survival. Gynecol Oncol 1996; 63: 28-33
  • 13. Fukuda K, MoriM, Uchiyama M, IwaiK, Iwasaka T, Sugimori H. Prognostic significance of progesterone receptor immuno his to chemistry in endometrial carcinoma. Gynecol Oncol 1998; 69: 220-5
  • 14. Sivridis E, GiatromanolakiA, Koukourakis M, Anastasiadis P. Endometrial carcinoma: association with low angiogenesis andbcl-2 expression. Vfrhows Arch 2001; 438: 470-7
  • 15. IwaiK, Fukuda K, Hachisuga T. Etal. Prognostic signicance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma. Gynecol Oncol 1999; 72: 351-9
  • 16. ZhaiYL, KobayashiY, Mori A et al. Expression of steroid receptors, Ki-67 and p 53 in uterine leiomyosarcomas. IntJ Gynecol Pathol 1999; 18: 20-8
  • 17. Mittal K, Demopoulos RI. MIB-1 (Ki-67), p 53, estrogen receptor and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 2001; 32: 984-7

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

Gözde KIR Bu kişi benim


Handan ÇETİNER Bu kişi benim


Ayşe GÜRBÜZ Bu kişi benim


Sadiye EREN Bu kişi benim

Yayımlanma Tarihi 1 Mayıs 2003
Yayınlandığı Sayı Yıl 2003, Cilt 34, Sayı 4

Kaynak Göster

Bibtex @ { zktipb236774, journal = {Zeynep Kamil Tıp Bülteni}, issn = {1300-7971}, eissn = {2148-4864}, address = {}, publisher = {Zeynep Kamil Kadın ve Çocuk Hastalıkları EAH}, year = {2003}, volume = {34}, pages = {19 - 21}, doi = {10.16948/zktb.87506}, title = {Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu}, key = {cite}, author = {Kır, Gözde and Çetiner, Handan and Gürbüz, Ayşe and Eren, Sadiye} }
APA Kır, G. , Çetiner, H. , Gürbüz, A. & Eren, S. (2003). Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu . Zeynep Kamil Tıp Bülteni , 34 (4) , 19-21 . Retrieved from https://dergipark.org.tr/tr/pub/zktipb/issue/22050/236774
MLA Kır, G. , Çetiner, H. , Gürbüz, A. , Eren, S. "Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu" . Zeynep Kamil Tıp Bülteni 34 (2003 ): 19-21 <https://dergipark.org.tr/tr/pub/zktipb/issue/22050/236774>
Chicago Kır, G. , Çetiner, H. , Gürbüz, A. , Eren, S. "Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu". Zeynep Kamil Tıp Bülteni 34 (2003 ): 19-21
RIS TY - JOUR T1 - Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu AU - Gözde Kır , Handan Çetiner , Ayşe Gürbüz , Sadiye Eren Y1 - 2003 PY - 2003 N1 - DO - T2 - Zeynep Kamil Tıp Bülteni JF - Journal JO - JOR SP - 19 EP - 21 VL - 34 IS - 4 SN - 1300-7971-2148-4864 M3 - UR - Y2 - 2021 ER -
EndNote %0 Zeynep Kamil Tıp Bülteni Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu %A Gözde Kır , Handan Çetiner , Ayşe Gürbüz , Sadiye Eren %T Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu %D 2003 %J Zeynep Kamil Tıp Bülteni %P 1300-7971-2148-4864 %V 34 %N 4 %R %U
ISNAD Kır, Gözde , Çetiner, Handan , Gürbüz, Ayşe , Eren, Sadiye . "Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu". Zeynep Kamil Tıp Bülteni 34 / 4 (Mayıs 2003): 19-21 .
AMA Kır G. , Çetiner H. , Gürbüz A. , Eren S. Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu. Zeynep Kamil Tıp Bülteni. 2003; 34(4): 19-21.
Vancouver Kır G. , Çetiner H. , Gürbüz A. , Eren S. Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu. Zeynep Kamil Tıp Bülteni. 2003; 34(4): 19-21.
IEEE G. Kır , H. Çetiner , A. Gürbüz ve S. Eren , "Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu", Zeynep Kamil Tıp Bülteni, c. 34, sayı. 4, ss. 19-21, May. 2003, doi:10.16948/zktb.87506